Subcutaneous Daratumumab Administration in the Thigh Vs Abdomen in Plasma Cell Disorders
Clinical trial NCT07075510 · RECRUITING
Trial details
- NCT number
- NCT07075510
- Sponsor
- University of Maryland, Baltimore
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-10-23
- Primary completion
- 2030-10-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.